Disclosure of material issue

September 21, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Regulation 30 - Disclosure to the public shareholders in connection with the proposed share swap involving Anlon Healthcare Limited (“Company”) Dear Sir/Madam, This is in continuation to the (i) Company's communication dated August 13, 2026, for issuing notice for convening 13th (Thirteenth) Annual General Meeting (“AGM”) on September 05, 2026 (“AGM Notice”), which inter alia included a proposal for approving the share swap of the equity shares of the Company in lieu of acquisition of 44.94% equity shareholding of Apiqo Organics Private Limited and 47.41% equity shareholding of Bizotic Lifescience Private Limited; and (b) a corrigendum dated August 25, 2026 (“Corrigendum”), to the AGM Notice pursuant to the observations made by Bombay Stock Exchange Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”) dated August 18, 2026 and August 19, 2026 respectively, in relation to the in- principle application made by the Company for issue and allotment of shares on preferential basis, on certain points under notice and explanatory statement forming part of the AGM Notice. The AGM was duly held on September 5, 2026, and the proposal for share swap has been duly approved by the requisite shareholders. Further to the issuance of the Corrigendum, the Company received further observations from the BSE on September 10, 2026 (“Second BSE Observations”), and the NSE on September 11, 2026 (“Second NSE Observations”), which have been duly responded to. However, in the interest of transparency and maintaining good corporate governance standards, the Company is making the following additional disclosures in connection with the proposed share swap under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“LODR Regulations”). This disclosure shall form an integral part of the AGM Notice read with Corrigendum which has already been circulated to shareholders of the Company and always be read in conjunction with this disclosure. It is made available on the website of the stock exchange i.e. BSE at www.bseindia.com, NSE at www.nseindia.com, and on the website of the Company at www.anlon.in. All other contents of the AGM Notice and Corrigendum, save and except as modified or supplemented by this disclosure, shall remain unchanged. The shareholders are therefore requested to note the revised clauses in AGM Notice read with Corrigendum. ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in 1. In Explanatory Statement of AGM Notice and with respect to Item No. 8, the point no. D. “Basis or justification for the price” stands revised and replaced as below: “D. Basis or justification for the price (including premium, if any) at which the offer or invitation is being made & Pricing of the preferential issue including the name and address of the valuer: In terms of the provisions of Section 62(1)(c) of the Act read with rule 13(1) of the Companies (Share Capital and Debentures) Rules, 2014 and rule 14 of Companies (Prospectus and Allotment of Securities) Rules, 2014, the price for the shares proposed to be issued on preferential basis, by way of private placement, shall be determined by the valuation report of a registered valuer. The equity shares of the Company are listed on the Stock Exchanges. The equity shares are frequently traded on BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”) in terms of the SEBI ICDR Regulations. In case of listed entities, allotment of shares/securities by way of preferential issue can be made at a price not less than the price as calculated in accordance with the provisions of Regulation 164 of the SEBI ICDR Regulations. NSE, being the stock exchange with higher trading volumes during the 90 trading days preceding the Relevant Date, has been considered as recognized stock exchange for determining the floor price in accordance with the SEBI ICDR Regulations. Following has been determined as per the pricing formula prescribed under Regulation 164 of the SEBI ICDR Regulations:  Volume weighted average price of the equity shares of the Company quoted on NSE, during the 90 trading days preceding the Relevant Date, i.e., Rs.17.85/- (Rupees Seventeen and Eighty Five paise Only) per equity share; or  Volume weighted average price of the equity shares of the Company quoted on NSE, during the 10 trading days preceding the Relevant Date, i.e., Rs.14.99/- (Rupees Fourteen and Ninety Nine Paise Only) per equity share. Accordingly, the floor price has been determined as Rs.17.85/- (Rupees Seventeen and Eighty Five Paise only) per equity share, in terms of Regulation 164 of the SEBI ICDR Regulations. Further, in terms of the provisions of Chapter V of the SEBI ICDR Regulations, and pursuant to Regulation 163(3) thereof, the Company has obtained a Valuation Report dated August 06, 2026, read with the revised Valuation Report dated September 1, 2026, from CA Gaurang Agarwal, an Independent Registered Valuer. The said Valuation Report dated September 1, 2026 determines the fair value of the equity shares of the Company at Rs.17.85/- (Rupees Seventeen and Eighty Five Paise only) per equity share. The address of the Independent Registered Valuer is B-10, Kamla Nagar, Agra, Uttar Pradesh – 282005. Therefore, the issue Price of Rs.17.85/- (Rupees Seventeen and Eighty Five Paise Only) is not less than the floor price determined as per the pricing formula prescribed under Regulation 164 of Chapter V of SEBI ICDR Regulations for the Preferential Issue of Equity Shares.” ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in A copy of the revised Valuation Report dated September 1, 2026, from CA Gaurang Agarwal, an Independent Registered Valuer, as referred hereinabove, is available on the following link: https://www.anlon.in/reports.php?subid=260&name=Preferential-Issue- Documents, on the website of the Company under the tab “Investors”. 2. In Explanatory Statement of AGM Notice and with respect to Item No. 8, point no. M. “The identity of the Natural Persons who are the ultimate beneficial owners of the shares proposed to be allotted and/or who ultimately control the proposed allottee” stands revised and replaced as below: “M. The identity of the Natural Persons who are the ultimate beneficial owners of the shares proposed to be allotted and/or who ultimately control the proposed allottee: Sr. Name of the Name of beneficial owners PAN of the beneficial No. Allottee of proposed allottee owners of proposed allottee 1 UNICORN FUND NISARG BBPPP3200A PRAFULBHAI THAKKAR 2 JIGNESH C JIGNESH ADKPP3933C PAREKH (HUF) PAREKH 3 PIYUSH SHAH PIYUSH SHAH AKEPS6343N 4 GHANSHYAM GHANSHYAM ABGPC3311H HASMUKHBHAI HASMUKHBHAI CHANABABA CHANABABA 5 NAYANKUMAR P NAYANKUMAR AICPP7331H PATEL HUF P PATEL 6 BHORANIYA MEHUL AMCPB9403G MEHUL AMRUTLAL AMRUTLAL HUF BHORANIYA 7 DARSHIT DARSHIT AWUPC4013B VIJAYBHAI VIJAYBHAI CHANDARANA CHANDARANA (HUF) 8 PARASKUMAR PARASKUMAR AFAPJ3856L JAIN (HUF) JAIN 9 AJAY RAMBHAI AJAY RAMBHAI AIBPM2276K MOKARIYA (HUF) MOKARIYA 10 MRUG JENISH JENISH AOLPM6668K KISHORBHAI KISHORBHAI (HUF) MRUG 11 MRUG DEVEN DEVEN AOLPM6667G KISHORBHAI KISHORBHAI (HUF) MRUG 12 SIROYA ASHWINBHAI AKOPS0281M ASHWINBHAI N SIROYA ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, [Showing first 8,000 characters — download PDF for full document]